Novavax raised its full-year adjusted revenue forecast on Wednesday, banking on higher sales tied to its vaccine supply ...

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA ...

The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its ...

The US Department of Health and Human Services (HHS) has planned to cancel $500m (£376m) in funding for mRNA vaccines being ...

U.S. Health Secretary Robert F. Kennedy Jr. has pulled $500 million in funding from mRNA vaccine research, according to the Department of Health and Human Services. “… The data ...

Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.